Morning Analyst Calls Briefing for Friday, November 18, 2022
Here's the second batch of analysts' research calls issued Friday morning.
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Domino’s Pizza (DPZ) upgraded to Buy from Neutral at Northcoast; tgt $460
> Pinnacle West (PNW) upgraded to Neutral from Sell at Guggenheim; tgt raised to $70
> Ross Stores (ROST) upgraded to Buy from Hold at Gordon Haskett; tgt $130
Downgrades:
> Chart Industries (GTLS) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $133
> Editas Medicine (EDIT) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $13
> Editas Medicine (EDIT) downgraded to Perform from Outperform at Oppenheimer; tgt lowered to $12
> HP Inc. (HPQ) downgraded to Neutral from Outperform at Credit Suisse
> RH (RH) downgraded to Neutral from Outperform at Wedbush; tgt lowered to $270
Others:
> 4D Molecular Therapeutics (FDMT) initiated with a Buy at H.C. Wainwright; tgt $36
> Akili Inc. (AKLI) initiated with a Neutral at BofA Securities; tgt $2
> Amgen (AMGN) initiated with an Underperform at Credit Suisse; tgt $240
> Arcus Biosciences (RCUS) initiated with a Neutral at BofA Securities; tgt $33
> Bristol-Myers (BMY) initiated with a Neutral at Credit Suisse; tgt $78
> Conagra (CAG) upgraded to Buy from Neutral at UBS; tgt raised to $41
> CoStar Group (CSGP) resumed with a Buy at BofA Securities; tgt $100
> DraftKings (DKNG) initiated with an Overweight at Piper Sandler; tgt $21
> Dragonfly Energy (DFLI) initiated with a Buy at Chardan Capital Markets; tgt $15
> Eli Lilly (LLY) initiated with an Outperform at Credit Suisse; tgt $395
> Fulgent Genetics (FLGT) initiated with an Outperform at Raymond James; tgt $45
> Insmed (INSM) initiated with a Buy at BofA Securities; tgt $39
> Johnson & Johnson (JNJ) initiated with a Neutral at Credit Suisse; tgt $170
> Merck (MRK) initiated with an Outperform at Credit Suisse; tgt $120
> NeoGames (NGMS) initiated with an Underperform at BofA Securities; tgt $16
> Pfizer (PFE) initiated with an Outperform at Credit Suisse; tgt $55
> Precigen (PGEN) initiated with an Overweight at Cantor Fitzgerald; tgt $7
Research calls posted earlier this morning are available here.
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.
